OrbiMed Advisors as of March 31, 2012
Portfolio Holdings for OrbiMed Advisors
OrbiMed Advisors holds 107 positions in its portfolio as reported in the March 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Pfizer (PFE) | 7.0 | $235M | 10M | 22.64 | |
Bristol Myers Squibb (BMY) | 4.9 | $165M | 4.9M | 33.75 | |
Gilead Sciences (GILD) | 4.2 | $140M | 2.9M | 48.86 | |
Watson Pharmaceuticals | 3.4 | $114M | 1.7M | 67.06 | |
Life Technologies | 2.9 | $97M | 2.0M | 48.82 | |
Biogen Idec (BIIB) | 2.8 | $93M | 734k | 126.00 | |
Merck & Co (MRK) | 2.7 | $92M | 2.4M | 38.40 | |
WellPoint | 2.7 | $92M | 1.2M | 73.80 | |
Incyte Corporation (INCY) | 2.6 | $89M | 4.6M | 19.30 | |
Abbott Laboratories (ABT) | 2.6 | $87M | 1.4M | 61.29 | |
UnitedHealth (UNH) | 2.5 | $85M | 1.4M | 58.94 | |
Medco Health Solutions | 2.5 | $85M | 1.2M | 70.30 | |
Aetna | 2.3 | $79M | 1.6M | 50.16 | |
Warner Chilcott Plc - | 2.3 | $79M | 4.7M | 16.81 | |
Onyx Pharmaceuticals | 2.1 | $71M | 1.9M | 37.68 | |
Humana (HUM) | 2.1 | $69M | 750k | 92.48 | |
Questcor Pharmaceuticals | 2.1 | $69M | 1.8M | 37.62 | |
Allergan | 2.0 | $67M | 707k | 95.43 | |
Thermo Fisher Scientific (TMO) | 1.8 | $60M | 1.1M | 56.38 | |
Impax Laboratories | 1.7 | $58M | 2.4M | 24.58 | |
Vivus | 1.7 | $58M | 2.6M | 22.36 | |
NxStage Medical | 1.6 | $53M | 2.7M | 19.27 | |
Elan Corporation | 1.4 | $47M | 3.1M | 15.01 | |
Baxter International (BAX) | 1.3 | $45M | 748k | 59.78 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.3 | $43M | 350k | 123.30 | |
Celgene Corporation | 1.2 | $42M | 537k | 77.52 | |
Medtronic | 1.2 | $40M | 1.0M | 39.19 | |
EXACT Sciences Corporation (EXAS) | 1.2 | $40M | 3.5M | 11.16 | |
Regeneron Pharmaceuticals (REGN) | 1.1 | $37M | 319k | 116.62 | |
BioMarin Pharmaceutical (BMRN) | 1.1 | $36M | 1.1M | 34.25 | |
Shire | 1.0 | $34M | 356k | 94.75 | |
Zimmer Holdings (ZBH) | 1.0 | $34M | 523k | 64.28 | |
Chemocentryx | 1.0 | $34M | 3.2M | 10.66 | |
ImmunoGen | 1.0 | $33M | 2.3M | 14.39 | |
OraSure Technologies (OSUR) | 0.9 | $32M | 2.8M | 11.49 | |
3SBio (SSRX) | 0.9 | $32M | 2.1M | 14.80 | |
Johnson & Johnson (JNJ) | 0.9 | $30M | 451k | 65.96 | |
Affymetrix | 0.9 | $30M | 6.9M | 4.27 | |
Pacira Pharmaceuticals (PCRX) | 0.8 | $28M | 2.4M | 11.54 | |
Dendreon Corporation | 0.8 | $28M | 2.6M | 10.66 | |
Antares Pharma | 0.8 | $28M | 8.6M | 3.23 | |
Neurocrine Biosciences (NBIX) | 0.8 | $27M | 3.4M | 7.97 | |
Sequenom | 0.8 | $26M | 6.5M | 4.07 | |
Insulet Corporation (PODD) | 0.8 | $25M | 1.3M | 19.14 | |
Affymax (AFFY) | 0.7 | $22M | 1.9M | 11.74 | |
Ariad Pharmaceuticals | 0.7 | $23M | 1.4M | 15.98 | |
Array BioPharma | 0.6 | $21M | 6.3M | 3.40 | |
Amarin Corporation (AMRN) | 0.6 | $21M | 1.8M | 11.32 | |
Stryker Corporation (SYK) | 0.6 | $20M | 362k | 55.48 | |
Forest Laboratories | 0.6 | $20M | 578k | 34.69 | |
Align Technology (ALGN) | 0.6 | $20M | 738k | 27.55 | |
Alexion Pharmaceuticals | 0.6 | $20M | 216k | 92.86 | |
Pernix Therapeutics Holdings | 0.6 | $19M | 2.1M | 9.00 | |
NPS Pharmaceuticals | 0.5 | $18M | 2.6M | 6.84 | |
Incyte Corp note 4.750%10/0 | 0.5 | $18M | 7.7M | 2.32 | |
Amgen (AMGN) | 0.5 | $17M | 256k | 67.97 | |
Hca Holdings (HCA) | 0.5 | $17M | 699k | 24.74 | |
Given Imaging | 0.5 | $15M | 819k | 18.73 | |
Valeant Pharmaceuticals Int | 0.4 | $13M | 248k | 53.69 | |
Human Genome Sciences | 0.4 | $13M | 1.6M | 8.24 | |
XOMA CORP Common equity shares | 0.4 | $13M | 4.5M | 2.77 | |
Perrigo Company | 0.4 | $12M | 118k | 103.31 | |
Dendreon Corp note | 0.4 | $12M | 15M | 0.80 | |
Complete Genomics | 0.3 | $12M | 4.2M | 2.82 | |
CIGNA Corporation | 0.3 | $12M | 235k | 49.25 | |
Express Scripts | 0.3 | $11M | 210k | 54.18 | |
D Fluidigm Corp Del (LAB) | 0.3 | $11M | 719k | 15.73 | |
Eli Lilly & Co. (LLY) | 0.3 | $11M | 272k | 40.27 | |
McKesson Corporation (MCK) | 0.3 | $11M | 124k | 87.77 | |
Natus Medical | 0.3 | $11M | 915k | 11.93 | |
Cardinal Health (CAH) | 0.3 | $9.7M | 225k | 43.11 | |
CareFusion Corporation | 0.3 | $9.6M | 370k | 25.93 | |
Endocyte | 0.3 | $9.5M | 1.9M | 4.98 | |
MAP Pharmaceuticals | 0.2 | $8.4M | 583k | 14.36 | |
K-V Pharmaceutical Company | 0.2 | $7.9M | 6.0M | 1.32 | |
Amylin Pharmaceuticals | 0.2 | $8.1M | 325k | 24.96 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $7.0M | 157k | 44.51 | |
Oncothyreon | 0.2 | $6.7M | 1.5M | 4.36 | |
Cubist Pharmaceuticals | 0.2 | $6.2M | 144k | 43.25 | |
St. Jude Medical | 0.2 | $6.4M | 145k | 44.31 | |
Hi-Tech Pharmacal | 0.2 | $5.9M | 164k | 35.93 | |
DaVita (DVA) | 0.2 | $5.9M | 65k | 90.17 | |
Hologic (HOLX) | 0.2 | $5.4M | 250k | 21.55 | |
Volcano Corporation | 0.2 | $5.3M | 185k | 28.38 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.1 | $4.9M | 119k | 41.01 | |
Uroplasty | 0.1 | $5.2M | 1.7M | 3.01 | |
Quest Diagnostics Incorporated (DGX) | 0.1 | $4.5M | 73k | 61.15 | |
Verastem | 0.1 | $4.5M | 409k | 10.93 | |
Boston Scientific Corporation (BSX) | 0.1 | $3.9M | 650k | 5.98 | |
Edwards Lifesciences (EW) | 0.1 | $3.6M | 50k | 72.74 | |
Salix Pharmaceuticals | 0.1 | $3.7M | 70k | 52.50 | |
Cynosure | 0.1 | $3.5M | 198k | 17.86 | |
Syneron Medical Ltd ord | 0.1 | $3.4M | 313k | 10.72 | |
CUBIST PHARM CONVERTIBLE security | 0.1 | $3.2M | 2.0M | 1.60 | |
Medivation | 0.1 | $2.5M | 34k | 74.71 | |
Anthera Pharmaceuticals | 0.1 | $2.8M | 1.3M | 2.21 | |
Celsion Corporation | 0.1 | $2.8M | 1.5M | 1.90 | |
Covance | 0.1 | $2.3M | 48k | 47.62 | |
Masimo Corporation (MASI) | 0.1 | $2.4M | 103k | 23.38 | |
Athersys | 0.1 | $2.5M | 1.6M | 1.55 | |
Biodel | 0.1 | $2.1M | 3.6M | 0.59 | |
Volcano Corporation note 2.875% 9/0 | 0.1 | $1.8M | 1.5M | 1.20 | |
China Nuokang Bio-Pharmaceutical (NKBP) | 0.0 | $1.2M | 373k | 3.19 | |
Solta Medical | 0.0 | $1.5M | 484k | 3.03 | |
XenoPort | 0.0 | $563k | 125k | 4.50 | |
Sinovac Biotech (SVA) | 0.0 | $508k | 249k | 2.04 | |
Trius Therapeutics | 0.0 | $437k | 82k | 5.36 |